ChemicalBook >> CAS DataBase List >>MTI-31

MTI-31

CAS No.
1567915-38-1
Chemical Name:
MTI-31
Synonyms
MTI-31;LXI-15029;HTH-01-091 TFA;Benzamide, N-methyl-3-[2-[(3S)-3-methyl-4-morpholinyl]-4-(3-oxa-8-azabicyclo[3.2.1]oct-8-yl)pyrido[2,3-d]pyrimidin-7-yl]-;mTOR kinase inhibitor,tissue factor,mTORC2,mTOR inhibitor,Inhibitor,EGFR mutant cancer,mTOR-TF axis,Mammalian target of Rapamycin,apoptosis,MTI 31,mTOR,inhibit,MTI31,mTORC1,lipid metabolism,tumor microenvironment
CBNumber:
CB35867368
Molecular Formula:
C26H30N6O3
Molecular Weight:
474.55
MDL Number:
MOL File:
1567915-38-1.mol
Last updated:2023-05-21 10:59:17

MTI-31 Properties

Density 1.275±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 8.33 mg/mL (17.55 mM; ultrasonic and warming and heat to 60°C)
pka 14.45±0.46(Predicted)
FDA UNII RM15YYQ1CI

MTI-31 Preparation Products And Raw materials

Raw materials

Preparation Products

MTI-31 Suppliers

Global( 16)Suppliers
Supplier Tel Email Country ProdList Advantage
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525 masar@topule.com China 8474 58
Aladdin Scientific
+1-833-552-7181 sales@aladdinsci.com United States 52927 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266 China 4153 55
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994 2853530910@QQ.com China 8011 62
DC Chemicals 021-58447131 13564518121 sales@dcchemicals.com China 9414 58
Absin Bioscience Inc. 021-38015121 15000105423 chenjw@absin.cn China 24734 58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd. +86-027-59232304 15387063101 2881924050@qq.com China 9892 58
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24018 58
MTI-31 Benzamide, N-methyl-3-[2-[(3S)-3-methyl-4-morpholinyl]-4-(3-oxa-8-azabicyclo[3.2.1]oct-8-yl)pyrido[2,3-d]pyrimidin-7-yl]- LXI-15029 mTOR kinase inhibitor,tissue factor,mTORC2,mTOR inhibitor,Inhibitor,EGFR mutant cancer,mTOR-TF axis,Mammalian target of Rapamycin,apoptosis,MTI 31,mTOR,inhibit,MTI31,mTORC1,lipid metabolism,tumor microenvironment HTH-01-091 TFA 1567915-38-1